Targeting TBK1 With GSK8612 Suppresses Kidney and Cardiac Inflammation and Fibrosis in DOCA /Salt Hypertension
Nephrology · 2026
DOI: 10.1111/nep.70166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nephrology, 2026. Verfasst von Jiamin Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Hypertension, Kidney, Protein Kinase Inhibitors. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Guangdong Medical Scientific Research Foundation, Foshan Science and Technology Innovation Project Incubation and Cultivation Program.
Abstract (Originalsprache)
Aim
To investigate the therapeutic potential of GSK8612, a selective TBK1 inhibitor, against the inflammatory and fibrotic pathological remodeling in the heart and kidneys induced by DOCA/salt hypertension in mice.
Methods
A salt‐sensitive hypertension model was established in male C57BL/6 mice via uninephrectomy followed by DOCA/salt treatment. Hypertensive mice were administered the selective TBK1 inhibitor GSK8612 (1.5 mg/kg, i.p., once every two days) or vehicle for 21 days. Blood pressure was monitored weekly. Renal and cardiac injury were assessed by histopathology, including Hematoxylin and Eosin, Sirius Red, and Masson's trichrome staining. Extracellular matrix deposition was evaluated via Western blot and immunofluorescence. Macrophage‐to‐myofibroblast transition was determined by F4/80 and α‐SMA co‐staining. Inflammatory cell infiltration was evaluated by immunohistochemistry, while cytokine mRNA levels were quantified by RT‐qPCR.
Results
While GSK8612 treatment showed no significant effect on blood pressure in DOCA/salt‐challenged mice, it significantly improved kidney function and attenuated kidney injury compared to DOCA/salt‐treated controls. GSK8612 treatment significantly inhibited myofibroblast accumulation and extracellular matrix deposition in the kidneys and reduced infiltration of inflammatory cells. Furthermore, it effectively inhibited macrophage‐to‐myofibroblast transition in hypertensive nephropathy. Notably, GSK8612 administration also ameliorated DOCA/salt‐induced cardiac inflammation and fibrosis, as evidenced by reduced infiltration of F4/80 + macrophages and decreased fibroblast activation.
Conclusion
Pharmacological inhibition of TBK1 with GSK8612 confers dual organ protection, attenuating both kidney and heart inflammation and fibrosis in a murine model of salt‐sensitive hypertension.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
- Department of Anesthesiology, Affiliated Foshan Women and Children Hospital, Guangdong Medical University, Foshan, China.
- Department of Anesthesiology, The Tenth Affiliated Hospital Southern of Medical University (Dongguan People's Hospital), Dongguan, China.
- Shenzhen School of Clinical Medicine, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
- Dongguan Key Laboratory of Anesthesia and Organ Protection, Dongguan, China.
ORCID-Profile: Haihui Xie, Hua Liang
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- Guangdong Medical Scientific Research Foundation
- Foshan Science and Technology Innovation Project Incubation and Cultivation Program
Zitieren
APA
Huang, J., Rong, W., Li, L., Yu, W., Chen, S., Xie, H., & Liang, H. (2026). Targeting TBK1 With GSK8612 Suppresses Kidney and Cardiac Inflammation and Fibrosis in DOCA /Salt Hypertension. Nephrology. https://doi.org/10.1111/nep.70166
Vancouver
Huang J, Rong W, Li L, Yu W, Chen S, Xie H, et al. Targeting TBK1 With GSK8612 Suppresses Kidney and Cardiac Inflammation and Fibrosis in DOCA /Salt Hypertension. Nephrology. 2026. doi:10.1111/nep.70166
BibTeX
@article{Huang2026,
author = {Huang, Jiamin and Rong, Wei and Li, Ling and Yu, Wenqiang and Chen, Shuangquan and Xie, Haihui and Liang, Hua},
title = {Targeting TBK1 With GSK8612 Suppresses Kidney and Cardiac Inflammation and Fibrosis in DOCA /Salt Hypertension},
journal = {Nephrology},
year = {2026},
doi = {10.1111/nep.70166}
}
EUVIMED